Refine
Year of publication
Document Type
- Article (32)
- Preprint (5)
- Review (2)
- Report (1)
- Working Paper (1)
Has Fulltext
- yes (41)
Is part of the Bibliography
- no (41)
Keywords
- Acuris (2)
- Decorin (2)
- Gene expression (2)
- IR-A (2)
- Pre-analytics (2)
- Proliferation (2)
- Signaling (2)
- ACURATE neo (1)
- ALL (1)
- AML (1)
- Amino acid analysis (1)
- Angiomyolipoma (1)
- Anlegerschutz (1)
- Anticonvulsant (1)
- BRCA1 (1)
- BRCA2 (1)
- Bacterial leakage (1)
- Bankberatung (1)
- Bike-Sharing (1)
- Blood sample handling (1)
- CAD/ CAM crown (1)
- CAD/CAM crown (1)
- CAKUT (1)
- Car-Sharing (1)
- Care centers (1)
- Cement gap (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Conometric connection (1)
- Consensus (1)
- Costs (1)
- DNA sequence analysis (1)
- Diagnostic differentiation (1)
- Elektromobilität (1)
- Embryos (1)
- Endocannabinoids (1)
- Endothelium (1)
- Epilepsy (1)
- Finanzbildung (1)
- Flottenkonzepte (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Genetics (1)
- Gesundheitspersonal (1)
- Gesundheitsversorgungseinrichtungen (1)
- Glioblastoma (1)
- Health facilities (1)
- Health personnel (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Isoproterenol (1)
- K3EDTA plasma sampling (1)
- Ladeinfrastruktur (1)
- Lipidomics (1)
- MGMT (1)
- MLL (1)
- MRI (1)
- MTOR inhibitor (1)
- Marginal integrity (1)
- Mesenchymal stem cells (1)
- Metabolomics (1)
- Microgap (1)
- Mobil-Stationen (1)
- Mutation databases (1)
- Noninferiority (1)
- Obesity (1)
- Panel testing (1)
- Patient portals (1)
- Patientenportale (1)
- Pedelecs (1)
- Peg3 (1)
- Plasma (1)
- Proteinkinase (1)
- Rare diseases (1)
- Renal lesions (1)
- SLC20A1 (1)
- Sampling protocol (1)
- Seizure (1)
- Seltene Erkrankungen (1)
- Serum (1)
- Sociodemographic characteristics (1)
- Subependymal giant cell astrocytoma (1)
- TAVR (1)
- TSC (1)
- Temozolomide (1)
- Transcriptome analysis (1)
- Umweltbilanz (1)
- VASP (1)
- Versorgungszentren (1)
- acute leukemia (1)
- acute myeloid leukemia (1)
- air pressure (1)
- angiostasis (1)
- aortic stenosis (1)
- autophagy (1)
- bacterial leakage (1)
- bioacoustics (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- cAMP (1)
- cGMP (1)
- cell therapy (1)
- chromosomal translocations (1)
- cloacal malformation (1)
- conical coupling (1)
- conometric connection (1)
- cytarabine dose (1)
- easyPACId (1)
- elderly (1)
- functional genetics (1)
- graft-versus host (1)
- hospital exemption (1)
- humidity (1)
- kidney formation (1)
- marginal fit (1)
- mesenchymal stromal cell (1)
- mitophagy (1)
- mitostatin (1)
- natural products (1)
- noise (1)
- proteobacteria (1)
- proteoglycans (1)
- refractory aGvHD (1)
- simplified production (1)
- soil temperature (1)
- steroid-resistant aGvHD (1)
- temperature (1)
- transcatheter aortic valve replacement (1)
- transfemoral (1)
- translocation partner genes (1)
- transplantation (1)
- urbanity gradient (1)
- urbanization (1)
- urinary tract development (1)
- zebrafish development (1)
Institute
- Medizin (24)
- Physik (9)
- Institut für Ökologie, Evolution und Diversität (2)
- Neuere Philologien (2)
- Sonderforschungsbereiche / Forschungskollegs (2)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (2)
- Biowissenschaften (1)
- Center for Financial Studies (CFS) (1)
- Geographie (1)
- House of Finance (HoF) (1)
Using the NA49 main TPC, the central production of hyperons has been measured in CERN SPS Pb - Pb collisions at 158 GeV c-1. The preliminary ratio, studied at 2.0 < y < 2.6 and 1 < pT < 3 GeV c-1, equals ~ (13 ± 4)% (systematic error only). It is compatible, within errors, with the previously obtained ratios for central S + S [1], S + W [2], and S + Au [3] collisions. The fit to the transverse momentum distribution resulted in an inverse slope parameter T of 297 MeV. At this level of statistics we do not see any noticeable enhancement of hyperon production with the increased volume (and, possibly, degree of equilibration) of the system from S + S to Pb + Pb. This result is unexpected and counterintuitive, and should be further investigated. If confirmed, it will have a significant impact on our understanding of mechanisms leading to the enhanced strangeness production in heavy-ion collisions.
Preliminary data on phi production in central Pb + Pb collisions at 158 GeV per nucleon are presented, measured by the NA49 experiment in the hadronic decay channel phi - K+K-. At mid-rapidity, the kaons were separated from pions and protons by combining dE/dx and time-of-flight information; in the forward rapidity range only dE/dx identification was used to obtain the rapidity distribution and a rapidity-integrated mt-spectrum. The mid-rapidity yield obtained was dN/dy = 1.85 ± 0.3 per event; the total phi multiplicity was estimated to be 5.0 ± 0.7 per event. Comparison with published pp data shows a slight, but not very significant strangeness enhancement.
Lambda and Antilambda reconstruction in central Pb+Pb collisions using a time projection chamber
(1997)
The large acceptance time projection chambers of the NA49 experiment are used to record the trajectory of charged particles from Pb + Pb collisions at 158 GeV per nucleon. Neutral strange hadrons have been reconstructed from their charged decay products. To obtain distributions of Λ, and Ks0 in discrete bins of rapidity, y, and transverse momentum, pT, calculations have been performed to determine the acceptance of the detector and the efficiency of the reconstruction software as a function of both variables. The lifetime distributions obtained give values of cτ = 7.8 ± 0.6 cm for Λ and cτ = 2.5 ± 0.3 cm for Ks0, consistent with data book values.
We present the first measurement of fluctuations from event to event in the production of strange particles in collisions of heavy nuclei. The ratio of charged kaons to charged pions is determined for individual central Pb+Pb collisions. After accounting for the fluctuations due to detector resolution and finite number statistics we derive an upper limit on genuine non-statistical fluctuations, perhaps related to a first or second order QCD phase transition. Such fluctuations are shown to be very small.
Two-particle correlation functions of negative hadrons over wide phase space, and transverse mass spectra of negative hadrons and deuterons near mid-rapidity have been measured in central Pb+Pb collisions at 158 GeV per nucleon by the NA49 experiment at the CERN SPS. A novel Coulomb correction procedure for the negative two-particle correlations is employed making use of the measured oppositely charged particle correlation. Within an expanding source scenario these results are used to extract the dynamic characteristics of the hadronic source, resolving the ambiguities between the temperature and transverse expansion velocity of the source, that are unavoidable when single and two particle spectra are analysed separately. The source shape, the total duration of the source expansion, the duration of particle emission, the freeze-out temperature and the longitudinal and transverse expansion velocities are deduced.
We report measurements of Xi and Xi-bar hyperon absolute yields as a function of rapidity in 158 GeV/c Pb+Pb collisions. At midrapidity, dN/dy = 2.29 +/- 0.12 for Xi, and 0.52 +/- 0.05 for Xi-bar, leading to the ratio of Xi-bar/Xi = 0.23 +/- 0.03. Inverse slope parameters fitted to the measured transverse mass spectra are of the order of 300 MeV near mid-rapidity. The estimated total yield of Xi particles in Pb+Pb central interactions amounts to 7.4 +/- 1.0 per collision. Comparison to Xi production in properly scaled p+p reactions at the same energy reveals a dramatic enhancement (about one order of magnitude) of Xi production in Pb+Pb central collisions over elementary hadron interactions.
The directed and elliptic flow of protons and charged pions has been observed from the semi-central collisions of a 158 GeV/nucleon Pb beam with a Pb target. The rapidity and transverse momentum dependence of the flow has been measured. The directed flow of the pions is opposite to that of the protons but both exhibit negative flow at low pt. The elliptic flow of both is fairly independent of rapidity but rises with pt. PACS numbers: 25.75.-q, 25.75.Ld
The large acceptance TPCs of the NA49 spectrometer allow for a systematic multidimensional study of two-particle correlations in different part of phase space. Results from Bertsch-Pratt and Yano-Koonin-Podgoretskii parametrizations are presented differentially in transverse pair momentum and pair rapidity. These studies give an insight into the dynamical space-time evolution of relativistic Pb+Pb collisions, which is dominated by longitudinal expansion.
The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three blinded readers (‘average reader’) was 83.7% for gadobutrol and 87.3% for gadopentate dimeglumine. The increase in accuracy from precontrast to combined precontrast and postcontrast MRI was 8.0% for gadobutrol and 6.9% for gadopentate dimeglumine. Sensitivity of the average reader was 85.2% for gadobutrol and 88.7% for gadopentate dimeglumine. Specificity of the average reader was 82.1% for gadobutrol and 86.1% for gadopentate dimeglumine. In conclusion, this study documents evidence for the noninferiority of a single i.v. bolus injection of 1.0 M gadobutrol compared with 0.5 M gadopentate dimeglumine in the diagnostic assessment of renal lesions with CE-MRI.